News Website

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - The Malaysian Reserve

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 18, 2025, 12:16 a.m.

Read Full Article

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - Yahoo Finance

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 17, 2025, 5:15 p.m.

Read Full Article

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - Newswire.ca

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 17, 2025, 5:15 p.m.

Read Full Article

A deeply frustrating line-by-line reading of Casey Costello’s letter to Health NZ - The Spinoff

A deeply frustrating line-by-line reading of Casey Costello’s letter to Health NZ The Spinoff

Published: April 17, 2025, 9:02 a.m.

Read Full Article

Aditxt Subsidiary Pearsanta Receives IRB Approval to Initiate Clinical Study of Blood-Based Diagnostic for Endometriosis with Patient Enrollment Planned to Begin in May 2025 - Quantisnow

Aditxt Subsidiary Pearsanta Receives IRB Approval to Initiate Clinical Study of Blood-Based Diagnostic for Endometriosis with Patient Enrollment Planned to Begin in May 2025 Quantisnow

Published: April 16, 2025, 12:15 p.m.

Read Full Article

Aditxt Subsidiary Pearsanta Receives IRB Approval to Initiate Clinical Study of Blood-Based Diagnostic for Endometriosis with Patient Enrollment Planned to Begin in May 2025 - Bluefield Daily Telegraph

Aditxt Subsidiary Pearsanta Receives IRB Approval to Initiate Clinical Study of Blood-Based Diagnostic for Endometriosis with Patient Enrollment Planned to Begin in May 2025 Bluefield Daily Telegraph

Published: April 16, 2025, 12:14 p.m.

Read Full Article

Beyond CRISPR: Brink Therapeutics raises $4 million with engineered recombinases - Labiotech.eu

Beyond CRISPR: Brink Therapeutics raises $4 million with engineered recombinases Labiotech.eu

Published: April 16, 2025, 6:33 a.m.

Read Full Article

Doctor who survived breast cancer names 'three food types' linked to disease - The Mirror

Doctor who survived breast cancer names 'three food types' linked to disease The Mirror

Published: April 14, 2025, 2:20 p.m.

Read Full Article

Kenny Logan's vow as he leads 555-mile motor neurone disease charity cycle with wife Gabby Logan - The Scotsman

Kenny Logan's vow as he leads 555-mile motor neurone disease charity cycle with wife Gabby Logan The Scotsman

Published: April 13, 2025, 11:01 p.m.

Read Full Article

My casework is about providing real support when you're stuck, says Inverclyde MP - Greenock Telegraph

My casework is about providing real support when you're stuck, says Inverclyde MP Greenock Telegraph

Published: April 13, 2025, 4:25 a.m.

Read Full Article

Latest Articles

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - The Malaysian Reserve

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - Yahoo Finance

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - Newswire.ca

A deeply frustrating line-by-line reading of Casey Costello’s letter to Health NZ - The Spinoff

Aditxt Subsidiary Pearsanta Receives IRB Approval to Initiate Clinical Study of Blood-Based Diagnostic for Endometriosis with Patient Enrollment Planned to Begin in May 2025 - Quantisnow

Aditxt Subsidiary Pearsanta Receives IRB Approval to Initiate Clinical Study of Blood-Based Diagnostic for Endometriosis with Patient Enrollment Planned to Begin in May 2025 - Bluefield Daily Telegraph

Beyond CRISPR: Brink Therapeutics raises $4 million with engineered recombinases - Labiotech.eu

Doctor who survived breast cancer names 'three food types' linked to disease - The Mirror

Kenny Logan's vow as he leads 555-mile motor neurone disease charity cycle with wife Gabby Logan - The Scotsman

My casework is about providing real support when you're stuck, says Inverclyde MP - Greenock Telegraph

Subscribe to Our Newsletter